Page 512 of 1,038: studies 5,111 to 5,120 of 10,380, newest first. Back to the depression overview
February 17, 2026 Linda A. Parker
The mysteries of the brain’s own cannabinoid system exposed and explained. Though cannabis has been used, for pain or pleasure, for over 4000 years, only lately have we learned, first, what makes it work and, more recently, how. Unraveling the mystery of the human brain’s special relationship with a psychoactive chemical derived from a plant—tetrahydrocannabinol, or THC,...
Qualitative Health Research February 17, 2026 Zaynab Khan, Sterre Weaver, Rachael V. Dando et al. 1 citation
People with cancer often experience anxiety and depression following a diagnosis and can face barriers to accessing treatment for their mental health. An increasing number of patients are considering alternative approaches to managing their mental health symptoms, such as the psychedelic, psilocybin. A growing number of clinical trials show significant and enduring improvements in mood and...
February 16, 2026 Chelsea J Siwik, Hallie Tankha, Jacob D Hill et al.
BACKGROUND Migraine ranks among the leading causes of disability worldwide. Comorbid depressive symptoms are highly prevalent in patients with migraine and are associated with worsened pain severity, greater migraine-related disability, and poorer migraine prognosis. Despite this burdensome comorbidity, the treatment of these co-occurring disorders has rarely been studied. While...
International Journal For Multidisciplinary Research February 15, 2026 Sonia Jasrotia, Chinmoyee Maharana
Mindfulness is the practice of being present and fully engaged in the moment, often cultivated through meditation and reflective practices. Mindfulness in education can create a revolution by enhancing emotional intelligence, resilience, and empathy among students/learners. In this paper, we will discuss the importance of mindfulness in Education, how mindful practices can reduce stress,...
Journal of Pain Research and Management February 14, 2026 Flávia C.S. Fonseca, Daniel P.D. Machado, André D. Cavalcante et al.
1. Dos Santos RG, Hallak JEC. Ayahuasca: pharmacology, safety, and therapeutic effects. CNS Spectr. 2024 Nov 20;30(1):e2. 2. Bouso JC, González D, Fondevila S, Cutchet M, Fernández X, Ribeiro Barbosa PC, et al. Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of Ayahuasca: a longitudinal study. PLoS One. 2012;7(8):e42421. 3. Sarris J, Perkins D,...
Ganaya February 14, 2026 Tinon Citraning Harisuci, Vikri Islah Khafidz, Faricha Annisa et al.
Individuals with mental disabilities are vulnerable to anxiety, stress, and depression that affect emotional and social functioning. This study aimed to evaluate the effect of Dance Movement Therapy (DMT) accompanied by Osho Kundalini music on reducing symptoms of anxiety, stress, and depression. The study employed a pre-experimental one-group pretest–posttest design involving 15 participants...
The Effect of Exercise on Emotion February 13, 2026 Marie Grace Avelino Gomez, Ervin T. Echague
Depression and anxiety are among the most widespread mental health challenges globally, impairing functioning, relationships, and overall well-being. While psychotherapy and pharmacological treatments remain central, they are not wholly sufficient in addressing the lived experiences of those affected. This chapter explores the therapeutic potential of mindfulness, movement, and dance as...
Open Mind February 13, 2026 John Moriarty, Alan Robert Bowman, Alison Pocock preprint
Psychedelics are psychoactive substances that alter one's perception, cognition and emotion, as well as one's sense of time, place and self (Nutt, 2023, p.19). Psychedelic-assisted therapy (PAT) involves the carefully controlled administration of a psychedelic substance "alongside structured psychological support, including preparation, guidance during the psychedelic session, and post-session...
Future Health February 13, 2026 Anita Verma, Ravisankar Thamilarasan, Harshit Kumar
Psychiatric disorders represent a leading cause of global disability yet current therapeutic strategies, based mainly on monoaminergic modulation, exhibit limited efficacy and high relapse rates for a significant patient population. This has catalyzed a paradigm shift toward understanding the biological underpinnings of mental illness. This review synthesises evidence from three rapidly...
Psychiatry Research February 13, 2026 Sean P. Goldy, Nathan D. Sepeda, Samantha Hilbert et al. 1 citation
Psychedelics' characteristic acute subjective effects predict therapeutic benefits, such as decreases in depression and anxiety. Thus, optimizing treatment involves better understanding which factors shape subjective effects. Session facilitators, who support participants before, during, and after psychedelic administration sessions, form an important part of the setting of these experiences....